This study investigates the effect of dietary supplementation on cognitive Performance and mood in university students over a 60-day period using a double-blind randomized controlled design. This study includes 75 participants, aged 18 or older. Participants will be randomly assigned to group I (n=25; will receive the supplement one), group II (n=25; will receive the supplement two), and group III (n=25; control/placebo). Assessments will be conducted before starting supplementation, 30 days after, and at the end of the intervention to determine the effect of the supplementation on cognitive performance and mood. The main outcomes include cognitive status and mood measured by Depression Anxiety Stress Scales - (DASS), Brief Symptom Inventory (BSI) and Self-efficacy scale in higher education. Adherence to supplementation and potential side effects will also be assessed. Based on the data obtained at these three assessment points, it will be possible to qualitatively address the actual effect of supplements on students' cognitive performance. In addition, the participants nutritional status will also be assessed using the Simplified Appetite Nutrition Questionnaire (SANQ) and their perception of it using the Visual Appetite Scale (VAS). Both measurements will take place before the start of supplementation and at the end of the intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
75
Dietary Supplements Participants in this arm will receive a daily dose of two dietary supplement for 60 consecutive days. The supplements are administered orally and aims to improve cognitive performance in university students. Participants will also complete cognitive assessments before starting supplementation, 30 days after, and at the end of the intervention
Participants in this arm will receive a daily dose of an inert placebo that matches the supplement in appearance, taken orally for 60 consecutive days. The placebo is used as a control to compare the effects of the dietary supplement on cognitive performance. Participants will undergo the same cognitive assessments as the experimental groups.
Escola Superior de Saúde do Vale do Ave
Vila Nova de Famalicão, Braga District, Portugal
Cognitive performance
Change in cognitive performance measured Self-efficacy scale in higher education before starting supplementation, 30 days after, and at the end of the intervention. For reference, scores in the different dimensions (academic, higher education regulation, and social interaction) equal to or less than 3 indicate low levels of self-efficacy in the respective dimension. In turn, scores equal to or greater than 5 correspond to robust self-efficacy beliefs.
Time frame: Baseline, 30 days and 60 days
Mood assessment
Change in mood is measured by DASS before starting supplementation, 30 days after, and at the end of the intervention. In the DASS, the scores are presented as a total score (between 0 and 63) and a score for the three subscales (between 0 and 21). The scores for each subscale are categorized into five degrees of severity: normal, mild, moderate, severe, and extremely severe. The higher the score, the greater the degree of severity.
Time frame: Baseline, 30 days and 60 days]
Psychological Pathology Assessment
Psychological pathology assessment is measured by BSI before starting supplementation, 30 days after, and at the end of the intervention. BSI is assessed by calculating the Overall Severity Index (OSI), adding up all items on the BSI-18. OSI values ≥ 63 indicate psychological pathology.
Time frame: Baseline, 30 days and 60 days]
Nutrition assessment
The shorter version of the Nutrition Council Appetite Assessment Questionnaire-the Simplified Appetite Nutrition Questionnaire (SANQ)-is being used in this study as a tool for measuring appetite in the group of participants. The SANQ consists of four items, grouped into a single domain. When added together, they generate the total questionnaire score, which can range from 4 to 20. The lower the score, the greater the risk of weight loss. In the original instrument, scores lower than or equal to 14 indicate a risk of weight loss of at least 5% in six months. Participants will be assessed before taking the dietary supplement and 60 days after.
Time frame: Baseline and 60 days
Appetite assessment
Before the intervention and 60 days afterward, participants will be asked to rate their appetite using a visual appetite scale (VAS) to check for any changes and complete a simplified nutritional assessment questionnaire. This scale consists of a 100 mm long line without graduations, and participants should be instructed to mark a cross or a vertical line at the point on the scale where they consider their appetite to be. The point marked by the individual should be measured with the aid of a ruler, from the left end (minimum score zero mm) to the right (maximum score 100 mm), in order to quantify the resulting measurements. The results should be evaluated using the two measurement points. If the values remain the same, taking the supplements had no significant impact on the subjective perception of appetite.
Time frame: Baseline and 60 days
Adherence to supplementation
Adherence will be monitored through a daily intake diary completed by participants, in which each participant will record their daily consumption of the supplement or placebo during the 60-day period. The record includes the day, month, and year. Participants will also complete a questionnaire on the occurrence of side effects at the end of the intervention (60 days).
Time frame: 60 days
Evaluation of tolerance
Participants will also complete a questionnaire on the occurrence of side effects (absent, mild, moderate and severe) at the end of the intervention (60 days).
Time frame: 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.